Marzaro G - Search Results

1

Molecular Mechanism of Action of Trimethylangelicin Derivatives as CFTR Modulators.

Laselva O, Marzaro G, Vaccarin C, Lampronti I, Tamanini A, Lippi G, Gambari R, Cabrini G, Bear CE, Chilin A, Dechecchi MC. Laselva O, et al. Among authors: marzaro g. Front Pharmacol. 2018 Jul 4;9:719. doi: 10.3389/fphar.2018.00719. eCollection 2018. Front Pharmacol. 2018. PMID: 30022950 Free PMC article.

2

A novel convenient synthesis of benzoquinazolines.

Marzaro G, Chilin A, Pastorini G, Guiotto A. Marzaro G, et al. Org Lett. 2006 Jan 19;8(2):255-6. doi: 10.1021/ol052594m. Org Lett. 2006. PMID: 16408888

3

Synthesis and antitumor activity of novel amsacrine analogs: the critical role of the acridine moiety in determining their biological activity.

Chilin A, Marzaro G, Marzano C, Dalla Via L, Ferlin MG, Pastorini G, Guiotto A. Chilin A, et al. Among authors: marzaro g. Bioorg Med Chem. 2009 Jan 15;17(2):523-9. doi: 10.1016/j.bmc.2008.11.072. Epub 2008 Dec 6. Bioorg Med Chem. 2009. PMID: 19101158

4

New vandetanib analogs: fused tricyclic quinazolines with antiangiogenic potential.

Conconi MT, Marzaro G, Guiotto A, Urbani L, Zanusso I, Tonus F, Tommasini M, Parnigotto PP, Chilin A. Conconi MT, et al. Among authors: marzaro g. Invest New Drugs. 2012 Apr;30(2):594-603. doi: 10.1007/s10637-010-9621-1. Epub 2010 Dec 24. Invest New Drugs. 2012. PMID: 21184131

5

Benzoquinazoline derivatives as new agents affecting DNA processing.

Marzaro G, Dalla Via L, Toninello A, Guiotto A, Chilin A. Marzaro G, et al. Bioorg Med Chem. 2011 Feb 1;19(3):1197-204. doi: 10.1016/j.bmc.2010.12.037. Epub 2010 Dec 19. Bioorg Med Chem. 2011. PMID: 21216603

6

Using the TOPS-MODE approach to fit multi-target QSAR models for tyrosine kinases inhibitors.

Marzaro G, Chilin A, Guiotto A, Uriarte E, Brun P, Castagliuolo I, Tonus F, González-Díaz H. Marzaro G, et al. Eur J Med Chem. 2011 Jun;46(6):2185-92. doi: 10.1016/j.ejmech.2011.02.072. Epub 2011 Mar 11. Eur J Med Chem. 2011. PMID: 21447431

7

Psoralenquinones as a novel class of proteasome inhibitors: design, synthesis and biological evaluation.

Marzaro G, Gandin V, Marzano C, Guiotto A, Chilin A. Marzaro G, et al. ChemMedChem. 2011 Jun 6;6(6):996-1000. doi: 10.1002/cmdc.201100041. Epub 2011 Apr 6. ChemMedChem. 2011. PMID: 21472862 No abstract available.

8

Development of a novel furocoumarin derivative inhibiting NF-κB dependent biological functions: design, synthesis and biological effects.

Borgatti M, Chilin A, Piccagli L, Lampronti I, Bianchi N, Mancini I, Marzaro G, dall'Acqua F, Guiotto A, Gambari R. Borgatti M, et al. Among authors: marzaro g. Eur J Med Chem. 2011 Oct;46(10):4870-7. doi: 10.1016/j.ejmech.2011.07.032. Epub 2011 Jul 23. Eur J Med Chem. 2011. PMID: 21864947

9

Quinazoline derivatives as potential anticancer agents: a patent review (2007 - 2010).

Marzaro G, Guiotto A, Chilin A. Marzaro G, et al. Expert Opin Ther Pat. 2012 Mar;22(3):223-52. doi: 10.1517/13543776.2012.665876. Epub 2012 Mar 12. Expert Opin Ther Pat. 2012. PMID: 22404097 Review.

10

Psoralen derivatives as inhibitors of NF-κB/DNA interaction: synthesis, molecular modeling, 3D-QSAR, and biological evaluation.

Marzaro G, Guiotto A, Borgatti M, Finotti A, Gambari R, Breveglieri G, Chilin A. Marzaro G, et al. J Med Chem. 2013 Mar 14;56(5):1830-42. doi: 10.1021/jm3009647. Epub 2013 Feb 25. J Med Chem. 2013. PMID: 23414143

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

66 results

Search Page